225 related articles for article (PubMed ID: 25320314)
1. Selective acquisition of host-derived ICAM-1 by HIV-1 is a matrix-dependent process.
Jalaguier P; Cantin R; Maaroufi H; Tremblay MJ
J Virol; 2015 Jan; 89(1):323-36. PubMed ID: 25320314
[TBL] [Abstract][Full Text] [Related]
2. Interaction between the cytoplasmic domain of ICAM-1 and Pr55Gag leads to acquisition of host ICAM-1 by human immunodeficiency virus type 1.
Beauséjour Y; Tremblay MJ
J Virol; 2004 Nov; 78(21):11916-25. PubMed ID: 15479832
[TBL] [Abstract][Full Text] [Related]
3. Basic motifs target PSGL-1, CD43, and CD44 to plasma membrane sites where HIV-1 assembles.
Grover JR; Veatch SL; Ono A
J Virol; 2015 Jan; 89(1):454-67. PubMed ID: 25320329
[TBL] [Abstract][Full Text] [Related]
4. Conserved Interaction of Lentiviral Vif Molecules with HIV-1 Gag and Differential Effects of Species-Specific Vif on Virus Production.
Zheng W; Ling L; Li Z; Wang H; Rui Y; Gao W; Wang S; Su X; Wei W; Yu XF
J Virol; 2017 Apr; 91(7):. PubMed ID: 28122978
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
6. The phosphorylation of HIV-1 Gag by atypical protein kinase C facilitates viral infectivity by promoting Vpr incorporation into virions.
Kudoh A; Takahama S; Sawasaki T; Ode H; Yokoyama M; Okayama A; Ishikawa A; Miyakawa K; Matsunaga S; Kimura H; Sugiura W; Sato H; Hirano H; Ohno S; Yamamoto N; Ryo A
Retrovirology; 2014 Jan; 11():9. PubMed ID: 24447338
[TBL] [Abstract][Full Text] [Related]
7. Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.
Anderson-Daniels J; Singh PK; Sowd GA; Li W; Engelman AN; Aiken C
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413124
[TBL] [Abstract][Full Text] [Related]
8. Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth.
Caccuri F; Giagulli C; Reichelt J; Martorelli D; Marsico S; Bugatti A; Barone I; Rusnati M; Guzman CA; Dolcetti R; Caruso A
J Virol; 2014 May; 88(10):5706-17. PubMed ID: 24623414
[TBL] [Abstract][Full Text] [Related]
9. The role of matrix in HIV-1 envelope glycoprotein incorporation.
Tedbury PR; Freed EO
Trends Microbiol; 2014 Jul; 22(7):372-8. PubMed ID: 24933691
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor.
Bachand F; Yao XJ; Hrimech M; Rougeau N; Cohen EA
J Biol Chem; 1999 Mar; 274(13):9083-91. PubMed ID: 10085158
[TBL] [Abstract][Full Text] [Related]
11. Membrane Binding of HIV-1 Matrix Protein: Dependence on Bilayer Composition and Protein Lipidation.
Barros M; Heinrich F; Datta SAK; Rein A; Karageorgos I; Nanda H; Lösche M
J Virol; 2016 May; 90(9):4544-4555. PubMed ID: 26912608
[TBL] [Abstract][Full Text] [Related]
12. A temporospatial map that defines specific steps at which critical surfaces in the Gag MA and CA domains act during immature HIV-1 capsid assembly in cells.
Robinson BA; Reed JC; Geary CD; Swain JV; Lingappa JR
J Virol; 2014 May; 88(10):5718-41. PubMed ID: 24623418
[TBL] [Abstract][Full Text] [Related]
13. Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.
Morikawa Y; Zhang WH; Hockley DJ; Nermut MV; Jones IM
J Virol; 1998 Sep; 72(9):7659-63. PubMed ID: 9696871
[TBL] [Abstract][Full Text] [Related]
14. Matrix mediates the functional link between human immunodeficiency virus type 1 RNA nuclear export elements and the assembly competency of Gag in murine cells.
Sherer NM; Swanson CM; Papaioannou S; Malim MH
J Virol; 2009 Sep; 83(17):8525-35. PubMed ID: 19535446
[TBL] [Abstract][Full Text] [Related]
15. The C-terminal p6 domain of the HIV-1 Pr55
Dubois N; Khoo KK; Ghossein S; Seissler T; Wolff P; McKinstry WJ; Mak J; Paillart JC; Marquet R; Bernacchi S
RNA Biol; 2018; 15(7):923-936. PubMed ID: 29954247
[TBL] [Abstract][Full Text] [Related]
16. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
Accola MA; Strack B; Göttlinger HG
J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.
Rye-McCurdy TD; Nadaraia-Hoke S; Gudleski-O'Regan N; Flanagan JM; Parent LJ; Musier-Forsyth K
J Virol; 2014 Jul; 88(14):7852-61. PubMed ID: 24789780
[TBL] [Abstract][Full Text] [Related]
18. Presence of host ICAM-1 in human immunodeficiency virus type 1 virions increases productive infection of CD4+ T lymphocytes by favoring cytosolic delivery of viral material.
Tardif MR; Tremblay MJ
J Virol; 2003 Nov; 77(22):12299-309. PubMed ID: 14581566
[TBL] [Abstract][Full Text] [Related]
19. The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation.
Murphy RE; Saad JS
Viruses; 2020 May; 12(5):. PubMed ID: 32429351
[TBL] [Abstract][Full Text] [Related]
20. RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production.
Ramalingam D; Duclair S; Datta SA; Ellington A; Rein A; Prasad VR
J Virol; 2011 Jan; 85(1):305-14. PubMed ID: 20980522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
